Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2001-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1136/jnnp.71.6.777PMID 11723200PMCID PMC1737623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies

  1999cited by this paper
• CAMDEX : the Cambridge examination for mental disorders of the elderly

  1999cited by this paper
• 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.

  1998cited by this paper
• Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease.

  1998cited by this paper
• Systematic screening for mutations in the 5'-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder.

  1996cited by this paper
• Manchester and Oxford Universities Scale for the Psychopathological Assessment of Dementia (MOUSEPAD)

  1996cited by this paper
• Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples.

  1996cited by this paper
• Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type.

  1987cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• Dopaminergic sub-network connectivity alterations are associated with postoperative cognitive dysfunction: Results from the observational BioCog cohort study.

  2026cites this paper
• Oxidative Stress and Renal Function Decline in Type 2 Diabetes Mellitus: A Cross-Sectional Study from Samarra General Hospital

  2025cites this paper
• Neurobiology of Behavioral and Psychological Symptoms of Dementia

  2025cites this paper
• Plasma biomarkers in neuropsychiatric syndromes: A narrative review

  2025cites this paper
• Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease

  2024cites this paper
• Distinguishing features of depression in dementia from primary psychiatric disease

  2024cites this paper
• IL_33 as a Modulator of Neuroinflammation in Alzheimer’s disease: An ELISA Approach

  2024cites this paper
• Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms

  2024cites this paper
• Unique Transcriptional Signatures Correlate with Behavioral and Psychological Symptom Domains in Alzheimer’s Disease

  2023cites this paper
• Neuropsychiatric Symptoms of Alzheimer’s Disease: An Anatomic-Genetic Framework for Treatment Development

  2023cites this paper
• Pathogenesis of Depression in Alzheimer’s Disease

  2023cites this paper
• The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT– and rTg(P301L)4510 mouse models of Alzheimer's disease

  2022cites this paper
• Managing Behavioral and Psychological Symptoms of Dementia (BPSD) in the Era of Boxed Warnings

  2022cites this paper
• Association of the MAOB rs1799836 Single Nucleotide Polymorphism and APOE ɛ4 Allele in Alzheimer's Disease.

  2021cites this paper
• Alterations and interactions of subcortical modulatory systems in Alzheimer's disease.

  2021cites this paper
• Neuropathology of the Brainstem to Mechanistically Understand and to Treat Alzheimer’s Disease

  2021cites this paper
• Neurogenetics, Genome-Wide Association and Candidate Gene Studies

  2020cites this paper
• Delusions in dementias

  2020cites this paper
• Pimavanserin for the treatment of psychosis in Alzheimer’s disease: A literature review

  2020cites this paper
• Schizophrenia, Not a Psychotic Disorder: Bleuler Revisited

  2019cites this paper
• Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer′s disease

  2019cites this paper
• The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches.

  2019cites this paper
• Relationships of Cerebrospinal Fluid Alzheimer’s Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms

  2019cites this paper
• The neurochemistry of agitation in Alzheimer's disease: a systematic review.

  2018cites this paper
• Hallucinations in Neurological Disorders

  2018cites this paper
• Psychiatric Disorders Late in Life

  2018cites this paper
• Effects of single administration of apomorphine on memory and monoamine metabolism: A dose related study.

  2018cites this paper
• Genetics of migration timing in bar-tailed godwits : a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Zoology at Massey University, Manawatū, New Zealand

  2018cites this paper
• Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review

  2018cites this paper
• Resveratrol Modulates and Reverses the Age-Related Effect on Adenosine-Mediated Signalling in SAMP8 Mice

  2018cites this paper
• Role of physical activity in ameliorating neuropsychiatric symptoms in Alzheimer disease: A narrative review

  2018cites this paper
• A Clinical and Neuropathological Study of 2 Families

  2017cites this paper
• Monoaminergic neuropathology in Alzheimer's disease

  2017cites this paper
• Genetics of psychosis of Alzheimer disease

  2017influential citation
• Biomarkers of aggression in dementia.

  2016cites this paper
• Genome-wide association study of aggressive behaviour in chicken

  2016cites this paper
• Delusions in Patients with Alzheimer’s Disease: A Multidimensional Approach

  2016cites this paper
• Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients

  2016cites this paper
• Child and Adolescent Psychiatry.

  2015cites this paper
• Behavioral and Psychological Symptoms in Alzheimer's Disease

  2014cites this paper
• Human Dopamine Receptors Interaction Network (DRIN): a systems biology perspective on topology, stability and functionality of the network.

  2014cites this paper
• Genetic epidemiology of psychotic symptoms and their treatment in dementia

  2014cites this paper
• Understanding delusion in dementia: A review

  2014cites this paper
• Alzheimer’s Disease: The Features and Quality of Life

  2014influential citation
• A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.

  2014cites this paper
• Characterising the neuropsychological profile of psychotic symptoms in Alzheimer's disease and imaging D2/3 receptor occupancy during treatment

  2014cites this paper
• Delusions in Alzheimer's Disease

  2014cites this paper
• Pharmacogenomics and Personalized Medicine in Alzheimer’s Disease

  2013cites this paper
• Metabolomics in Alzheimer's disease

  2013cites this paper
• Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.

  2013cites this paper
• Genetics and epigenetics of Alzheimer's disease

  2012influential citation
• No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias.

  2012cites this paper
• Behavioral Disturbance in Dementia

  2012cites this paper
• Hallucinations in Neurodegenerative Diseases

  2012cites this paper
• Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

  2012cites this paper
• Missense substitutions associated with behavioural disturbances in Alzheimer's disease (AD).

  2012cites this paper
• Dissecting anxiety-related QTLs in mice by univariate and multivariate mapping

  2012cites this paper
• Catechol-O-Methyltransferase GeneticVariant Associated with the Risk of Alzheimer’s Disease in a Brazilian Population

  2012cites this paper
• Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia.

  2012cites this paper
• LES TROUBLES PSYCHOTIQUES DANS LES DÉMENCES: QUAND LA PSYCHIATRIE CROISE LA NEUROLOGIE

  2011cites this paper
• A Multiple Indicators Multiple Causes (MIMIC) model of Behavioural and Psychological Symptoms in Dementia (BPSD).

  2011cites this paper
• Behavioural genetics of Alzheimer's disease: a comprehensive review

  2011influential citation
• Neurobiology of Delusions in Alzheimer’s Disease

  2011cites this paper
• Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality

  2011cites this paper
• Non-pharmacological management of behavioural symptoms of dementia.

  2011cites this paper
• Behavioral and Psychological Symptoms of Dementia: Part I—Epidemiology, Neurobiology, Heritability, and Evaluation

  2011cites this paper
• Genetics of Psychosis in Alzheimer's Disease: A Review

  2010influential citation
• Molecular Genetics of Aggressive Behaviour in Drosophila melanogaster

  2010cites this paper
• Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease.

  2010cites this paper
• Association of dopamine‐ and serotonin‐related genes with canine aggression

  2010cites this paper
• Neurochemical basis for symptomatic treatment of Alzheimer's disease.

  2010cites this paper
• Advances and perspectives from genetic research: development of biological markers in Alzheimer’s disease

  2010cites this paper
• Desarrollo del comportamiento antisocial: factores psicobiológicos, ambientales e interacciones genotipo-ambiente

  2009cites this paper
• Psychotic and behavioural symptoms in a population‐based sample of the very elderly subjects

  2009cites this paper
• Investigation of dopamine receptors in susceptibility to behavioural and psychological symptoms in Alzheimer's disease

  2009cites this paper
• Genes of the serotonergic and dopaminergic pathways and their interaction affect the expression of Behavioural and Psychological Symptoms in Dementia (BPSD).

  2009cites this paper
• Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis.

  2009cites this paper
• Dopamine D3 Receptor Gene Polymorphism Influences on Behavioral and Psychological Symptoms of Dementia (BPSD) in Mild Dementia of Alzheimer's Type

  2009cites this paper
• [The development of antisocial behavior: psychobiological and environmental factors and gene-environment interactions].

  2009cites this paper
• Searching for susceptibility genes for psychosis in late-onset Alzheimer's disease

  2009cites this paper
• TITLE Genes of the serotonergic and dopaminergic pathways and their interaction affect the expression of Behavioural and Psychological Symptoms in Dementia (BPSD): A Multiple Indicators Multiple Causes (MIMIC) approach.

  2009cites this paper
• Genetic Variation in the G720/G30 Gene Locus (DAOA) Influences the Occurrence of Psychotic Symptoms in Patients with Alzheimer's Disease

  2009cites this paper
• Neuropsychiatric symptoms in dementia: Importance and treatment considerations

  2008cites this paper
• Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review

  2008cites this paper
• Investigation of the Role of the Dopamine Transporter in Susceptibility to Behavioural and Psychological Symptoms of Patients with Probable Alzheimer’s Disease

  2008cites this paper
• Prominent Neuroleptic Sensitivity in a Case of Early-onset Alzheimer Disease due to Presenilin-1 G206A Mutation

  2008cites this paper
• Genetics of Alzheimer's Disease. A Rapidly Evolving Field

  2007cites this paper
• Prediction of psychosis onset in Alzheimer disease: The role of depression symptom severity and the HTR2A T102C polymorphism

  2007cites this paper
• Neuroleptic drugs in dementia: benefits and harm

  2006cites this paper
• Prediction of psychosis onset in Alzheimer disease: The role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes.

  2006cites this paper
• Repeated treatment with antidepressants enhances dopamine D1 receptor gene expression in the rat brain.

  2006cites this paper
• Delusion symptoms are associated with ApoE ε4 allelic variant at the early stage of Alzheimer's disease with late onset

  2006cites this paper
• Complex phenotypic analysis to identify genes which contribute to or modify the development of Alzheimer's disease

  2006cites this paper
• Investigating the molecular aetiology of Obsessive-compulsive disorder (OCD) and clinically-defined subsets of OCD

  2006cites this paper
• Use of antipsychotic medications among elderly residents in long‐term institutional care: a three‐year follow‐up

  2006cites this paper
• Four Components Describe Behavioral Symptoms in 1,120 Individuals with Late‐Onset Alzheimer's Disease

  2006influential citation
• Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis.

  2005cites this paper
• Psychiatric and behavioral symptoms in Alzheimer’s disease and other dementias: Etiology and management

  2005cites this paper
• Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.

  2004cites this paper
• Parkinsonian syndromes: Parkinson's disease dementia, dementia with Lewy bodies and progressive supranuclear palsy

  2004cites this paper